20-Year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia.
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: It is generally believed that after the first episode of schizophrenia, the risk of relapse decreases with time in patients who are stabilized. Many treatment guidelines recommend that after stabilization, antipsychotic treatment should be continued for 1-5 years, and longer exposure should be avoided if possible. However, there is no published evidence to substantiate this view. The authors used nationwide databases to investigate this issue. METHOD: Prospectively gathered nationwide register data were used to study the risk of treatment failure (psychiatric rehospitalization or death) after discontinuation of antipsychotic treatment. Multivariate Cox regression was used to assess outcomes among all patients hospitalized for the first time with a schizophrenia diagnosis in Finland during the period of 1996-2014 (N=8,719). RESULTS: The lowest risk of rehospitalization or death was observed for patients who received antipsychotic treatment continuously (adjusted hazard ratio=1.00), followed by patients who discontinued antipsychotic use immediately after discharge from the first hospital treatment (hazard ratio=1.63, 95% CI=1.52-1.75), within 1 year (hazard ratio=1.88, 95% CI=1.57-2.24), within 1-2 years (hazard ratio=2.12, 95% CI=1.43-3.14), within 2-5 years (hazard ratio=3.26, 95% CI=2.07-5.13), and after 5 years (a median of 7.9 years) (hazard ratio=7.28, 95% CI=2.78-19.05). Risk of death was 174%-214% higher among nonusers and patients with early discontinuation of antipsychotics compared with patients who received antipsychotic treatment continuously for up to 16.4 years. CONCLUSIONS: Whatever the underlying mechanisms, these results provide evidence that, contrary to general belief, the risk of treatment failure or relapse after discontinuation of antipsychotic use does not decrease as a function of time during the first 8 years of illness, and that long-term antipsychotic treatment is associated with increased survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.241 · Cited by 1,327
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
Tiihonen, J., Mittendorfer-Rutz, E., Majak, M., Mehtälä, J., Hoti, F., Jedenius, E., Enkusson, D., Leval, A., Sermon, J., Tanskanen, A., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1322 · Cited by 670
Self-citationVancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., & Korhonen, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081224 · Cited by 619
Self-citationWunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.19 · Cited by 567
Cannon, T. D., Kaprio, J., Lönnqvist, J., Huttunen, M., & Koskenvuo, M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.67 · Cited by 456
Tiihonen, J., Walhbeck, K., Lönnqvist, J., Klaukka, T., Ioannidis, J. P. A., Volavka, J., & Haukka, J. (2006) · BMJ · doi:10.1136/bmj.38881.382755.2f · Cited by 385
Self-citationHenderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Isohanni, M., M�kikyr�, T., Moring, J., R�sanen, P., Hakko, H., Partanen, U., Koiranen, M., & Jones, P. (1997) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00789044 · Cited by 275
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.182683 · Cited by 244
Gitlin, M., Nuechterlein, K., Subotnik, K. L., Ventura, J., Mintz, J., Fogelson, D. L., Bartzokis, G., & Aravagiri, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1835 · Cited by 217
Zipursky, R. B., Menezes, N. M., & Streiner, D. L. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.001 · Cited by 211
From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
Tanskanen, A., Taipale, H., Koponen, M., Tolppanen, A.-M., Hartikainen, S., Ahonen, R., & Tiihonen, J. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-015-0140-z · Cited by 199
Self-citationDecline in the Incidence of Schizophrenia in Finnish Cohorts Born From 1954 to 1965
Suvisaari, J. M., Haukka, J. K., Tanskanen, A. J., & Lönnqvist, J. K. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.733 · Cited by 148
Self-citationThe Scottish first episode schizophrenia study: VII. Two‐year follow‐up
Scottish Schizophrenia Research Group, McCreadie, R. G., Wiles, D., Grant, S., Crockett, G. T., Mahmood, Z., Livingston, M. G., Watt, J. A. G., Greene, J. G., Kershaw, P. W., et al. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb03032.x · Cited by 120
Takeuchi, H., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.021 · Cited by 115
Accuracy of register-based schizophrenia diagnoses in a genetic study
Mäkikyrö, T., Isohanni, M., Moring, J., Hakko, H., Hovatta, I., & Lönnqvist, J. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)80019-9 · Cited by 98
Gaebel, W., Riesbeck, M., Wölwer, W., Klimke, A., Eickhoff, M., von Wilmsdorff, M., Lemke, M., Heuser, I., Maier, W., Huff, W., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05459yel · Cited by 92
Taipale, H., Tanskanen, A., Koponen, M., Tolppanen, A.-M., Tiihonen, J., & Hartikainen, S. (2016) · Clinical Epidemiology · doi:10.2147/clep.s116160 · Cited by 72
Self-citationEmsley, R., Oosthuizen, P. P., Koen, L., Niehaus, D. J. H., & Martinez, G. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07138 · Cited by 69
Tiihonen, J., Tanskanen, A., Hoti, F., Vattulainen, P., Taipale, H., Mehtälä, J., & Lähteenvuo, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30134-7 · Cited by 58
Self-citationPurhonen, M., Koponen, H., Tiihonen, J., & Tanskanen, A. J. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3346 · Cited by 55
Self-citationDrug exposure in register-based research—An expert-opinion based evaluation of methods
Tanskanen, A., Taipale, H., Koponen, M., Tolppanen, A.-M., Hartikainen, S., Ahonen, R., & Tiihonen, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184070 · Cited by 49
Self-citationTakeuchi, H., Kantor, N., Sanches, M., Fervaha, G., Agid, O., & Remington, G. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.186007 · Cited by 44
Gäebel, W., Riesbeck, M., Wölwer, W., Klimke, A., Eickhoff, M., von Wilmsdorff, M., de Millas, W., Maier, W., Ruhrmann, S., Falkai, P., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.024 · Cited by 39
Boonstra, G., Burger, H., Grobbee, D. E., & Kahn, R. S. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.534801 · Cited by 38
Do antipsychotic drugs lose their efficacy for relapse prevention over time?
Leucht, S., & Davis, J. M. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.201103 · Cited by 32
Noguera, A., Ballesta, P., Baeza, I., Arango, C., de la Serna, E., González-Pinto, A. M., Parellada, M., Graell, M., Moreno, C., Otero, S., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182962480 · Cited by 29
Cited by
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Taipale, H., Tanskanen, A., Mehtälä, J., Vattulainen, P., Correll, C. U., & Tiihonen, J. (2020) · World Psychiatry · doi:10.1002/wps.20699 · Cited by 415
Self-citationTiihonen, J., Taipale, H., Mehtälä, J., Vattulainen, P., Correll, C. U., & Tanskanen, A. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4320 · Cited by 297
Self-citationKane, J. M., Schooler, N. R., Marcy, P., Correll, C. U., Achtyes, E. D., Gibbons, R. D., & Robinson, D. G. (2020) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2020.2076 · Cited by 208
Correll, C. U., Martin, A. L., Patel, C. A., Benson, C. J., Goulding, R., Sliwa, J. K., Joshi, K., Schiller, E., & Kim, E. (2022) · Schizophrenia · doi:10.1038/s41537-021-00192-x · Cited by 182
Metadata
- Authors
- Tiihonen, J., Tanskanen, A., & Taipale, H.
- Affiliations
- University of Eastern Finland (FI)
- Venue
- American Journal of Psychiatry
- Published
- 2018-08-01
- Volume
- 175
- Issue
- 8
- Pages
- 765-773
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2795999196
- Cited by
- 196
- References
- 31
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 23 · 2023: 17 · 2022: 23 · 2021: 29 · 2020: 25 · 2019: 26 · 2018: 11
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- first-episode schizophrenia, long-term antipsychotic treatment, relapse, psychiatric rehospitalization, mortality, treatment failure
- MeSH terms
- Adult, Female, Finland, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Recurrence, Registries, Risk Factors, Schizophrenia, Antipsychotic Agents, Proportional Hazards Models, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.